Comparsion of LigaSure and conventional techique in pancreaticoduodenectomy

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-13003455

Enrollment

Unknown

Registered

2013-03-05

Start date

2011-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

LigaSure:LigaSure resection

Conventional:Conventional resection

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Perioperative confirmed periampullary carcinoma, by: (1) CT; (2) MRI/MRCP; (3) Ultrasound/ultrasonography; (4) Endoscopic ultrasonography; (5) Endoscopic retrograde cholangiopancreatography; (6) PET-CT; (7) Biospy; 2. Aged 18-80 years old; 3. Port vein was involved, which can be reconstructed; 4. Performance status: KPS>=70; 5. No operation contraindication; 6. No distal metastasis or ascites; 7. Tumor have not invaded adjacent artery; 8. Written informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Benign periampullary lesion; 2. Image examination found unresectable, no distal metastasis or ascites; 3. With mental disease; 4. Impaired viscera function (cardiac function 34, ALT and/or AST exceed 3 times of the upper limit, Cr beyond the upper limit); 5. Complicated with other kind of malignancy; 6. Be or plan to be pregnant, or in lactation period.

Design outcomes

Primary

Measure	Time frame
Intra-operative blood loss;Duration of operation;	—

Secondary

Measure	Time frame
Postoperative stay;Complication;	—

Countries

China

Contacts

Public ContactZhiqian Hu

czhuzq@aliyun.com+86 21 81885591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026